Beckman Coulter to acquire Xitogen, 6/14

June 2014—Beckman Coulter entered into an agreement to acquire Xitogen Technologies together with Cytojene Corp. Xitogen, a flow cytometer developer based in Suzhou and Dalian, China, will provide Beckman Coulter Life Sciences with an operational base in the China market, and the facilities in Suzhou and Dalian will function as research and development and manufacturing centers.

Xitogen has developed the XTG-1600, a small footprint cytometer that can detect objects in the 100-nanometer range—viruses, bacteria, microparticles, and cell organelles—making it ideal for basic research investigations. The base single-laser, four-channel system can be incrementally expanded to a three-laser, 16-channel configuration.

Beckman Coulter Life Sciences, 800-742-2345